Quotes 5-day view Delayed Nyse
10/19/2020
10/20/2020
10/21/2020
10/22/2020
10/23/2020
Date
81.19(c)
81.14(c)
81.74(c)
81.45(c)
81.09(c)
Last
2 627 933
3 191 637
2 788 117
1 933 816
1 649 202
Volume
-0.77% -0.06% +0.74% -0.35% -0.44% Change
Sales 2020
11 422 M - -
Net income 2020
1 399 M - -
Net Debt 2020
1 401 M - -
P/E ratio 2020
30,1x
Yield 2020
1,18%
Sales 2021
12 103 M - -
Net income 2021
1 775 M - -
Net Debt 2021
745 M - -
P/E ratio 2021
23,6x
Yield 2021
1,33%
Capitalization
41 050 M 41 050 M -
EV / Sales 2020
3,72x
EV / Sales 2021
3,45x
Nbr of Employees
50 000
Free-Float
74,4%
Baxter International specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows:
- kidney dialysis drugs and equipment (52.1%);
- systems for delivering medications and intravenous therapy (24.6%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral...
Notations Surperformance© of Baxter International Inc.
Trading Rating : Investor Rating :
All news about BAXTER INTERNATIONAL INC.
News in other languages on BAXTER INTERNATIONAL INC.
Chart BAXTER INTERNATIONAL INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BAXTER INTERNATIONAL INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
19
Average target price
94,44 $
Last Close Price
81,09 $
Spread / Highest target
29,5%
Spread / Average Target
16,5%
Spread / Lowest Target
-9,98%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
